Evaluation of Fiasp® (Fast Acting Insulin Aspart) in 670G Hybrid Closed-Loop Therapy
Clinical trial NCT03554486 · COMPLETED
Trial details
- NCT number
- NCT03554486
- Sponsor
- Stanford University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-23
- Primary completion
- 2019-03-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.